EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells. (Q48005098)
Jump to navigation
Jump to search
scientific article published on 24 December 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells. |
scientific article published on 24 December 2016 |
Statements
1 reference
EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells. (English)
1 reference
Chun-Yu Liu
1 reference
Tzu-Ting Huang
1 reference
Chun-Teng Huang
1 reference
Ming-Hung Hu
1 reference
Duen-Shian Wang
1 reference
Wan-Lun Wang
1 reference
Wen-Chun Tsai
1 reference
Chia-Han Lee
1 reference
Ka-Yi Lau
1 reference
Hsiu-Ping Yang
1 reference
Ming-Huang Chen
1 reference
Chung-Wai Shiau
1 reference
Ling-Ming Tseng
1 reference
Kuen-Feng Chen
1 reference
24 December 2016
1 reference
1 reference
72
1 reference
112-123
1 reference
Identifiers
1 reference
1 reference